Patents matching “recombinant”

US 10370430

Recombinant factor VIII proteins

BIOVERATIV THERAPEUTICS INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

US 10364295

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

US 10294483

Eimeria tenella elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis

The United States of America, as represented by the Secretary of Agriculture · Granted May 21, 2019 · Expires May 16, 2039

US 10166285

Recombinant virus with diminished latency and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 1, 2019 · Expires Dec 27, 2038

US 10131701

Human leucine zipper/trail recombinant polypeptides

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 20, 2018 · Expires Nov 15, 2038

US 10105448

Combined enteropathogen recombinant construct

United States of America as represented by the Secretary of the Air Force · Granted Oct 23, 2018 · Expires Oct 18, 2038

US 10105434

Immune enhancing recombinant dengue protein

United States of America as represented by the Secretary of the Air Force · Granted Oct 23, 2018 · Expires Oct 18, 2038

US 10064933

Recombinant rift valley fever (RVF) viruses and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 4, 2018 · Expires Aug 30, 2038

US 10023650

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Jul 17, 2018 · Expires Jul 12, 2038

US 10010595

Live recombinant booster vaccine against tuberculosis

The Regents of the University of California · Granted Jul 3, 2018 · Expires Jun 28, 2038

US 9932564

Recombinant isfahan viral vectors

The Board of Regents of the University of Texas System · Granted Apr 3, 2018 · Expires Mar 29, 2038

US 9919040

Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof

The United States of America as represented by the Secretary of the Army · Granted Mar 20, 2018 · Expires Mar 15, 2038

US 9896484

Influenza virus recombinant proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 20, 2018 · Expires Feb 15, 2038

US 9879231

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2018 · Expires Jan 25, 2038

US 9850468

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2017 · Expires Dec 21, 2037

US 9839685

Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 12, 2017 · Expires Dec 7, 2037

US 9827295

Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase

Regents of the University of Minnesota · Granted Nov 28, 2017 · Expires Nov 23, 2037

US 9765378

Preparation method of new recombinant antibacterial polypeptide medicine

Creative Trio Biotech (Beijing) Co., Ltd. · Granted Sep 19, 2017 · Expires Sep 14, 2037

US 9683024

Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

The United States of America as represented by the Secretary of the Army · Granted Jun 20, 2017 · Expires Jun 15, 2037

US 9645147

Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protein HLA class I restricted T-cell epitopes

United States of America as represented by the Secretary of the Air Force · Granted May 9, 2017 · Expires May 4, 2037

US 9605077

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

US 9598697

Recombinant bacterium to decrease tumor growth

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9592304

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9587008

Method of producing recombinant vitamin K dependent proteins

APTEVO BIOTHERAPEUTICS LLC · Granted Mar 7, 2017 · Expires Mar 2, 2037